NCT02228746View on ClinicalTrials.gov

Effect of the Alpha-galacto-oligasaccharides on Weight Loss in Overweight or Moderately Obeses Adults : A Randomized Controlled Double Blinded Trial Versus Placebo

NACompletedINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2014

Conditions

Randomized Versus PlaceboControlledDouble Blind

Interventions

DIETARY_SUPPLEMENT

Alpha-galacto-oligosaccharides

6g of alpha-galacto-oligosaccharides in a 100 mL flavored drink

Trial Locations (1)

75013

Centre d'Investigation Clinique Paris-Est/ Bâtiment Antonin Gosset Hôpital de la Pitié Salpêtrière- 56 Boulevard Vincent Auriol, Paris

All Listed Sponsors

collaborator

Institute of Cardiometabolism and Nutrition, France

OTHER

lead

Olygose

INDUSTRY

NCT02228746 - Effect of the Alpha-galacto-oligasaccharides on Weight Loss in Overweight or Moderately Obeses Adults : A Randomized Controlled Double Blinded Trial Versus Placebo | Biotech Hunter | Biotech Hunter